Last update 07 Dec 2024

ETH-155036

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ETH-155036
Target
CDK6 x CSF-1R x FLT3
Mechanism
CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors), CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists), FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic DiseasesImmune System Diseases+ [1]
Active Indication
High Risk Myelodysplastic SyndromeRelapsing acute myeloid leukemiaAcute Lymphoblastic Leukemia+ [1]
Inactive Indication-
Originator Organization
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Active Organization
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Inactive Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with ETH-155036
Login to view more data
100 Translational Medicine associated with ETH-155036
Login to view more data
100 Patents (Medical) associated with ETH-155036
Login to view more data
100 Deals associated with ETH-155036
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
High Risk Myelodysplastic SyndromeIND Approval
CN
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
12 Oct 2023
Relapsing acute myeloid leukemiaIND Approval
CN
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
12 Oct 2023
Acute Lymphoblastic LeukemiaIND Application
CN
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
21 Jul 2023
Triple Negative Breast CancerPreclinical
CN
Shengke Pharmaceutical (Jiangsu) Co., Ltd.Shengke Pharmaceutical (Jiangsu) Co., Ltd.
30 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free